biotech · Rheumatoid Arthritis · Pharmacokinetics · XBIT
XBiotech Germany
XBiotech Germany GmbH
BBT Biotech is a biotech organization headquartered in Baesweiler, DE. It trades on NYSE under ticker XBIT. Primary therapeutic focus areas include Rheumatoid Arthritis, Pharmacokinetics, Staphylococcus Aureus Bacteremia
Baesweiler, DE HQ
30 Employees
Public company Type
XBIT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Baesweiler, DE
- Employees
- 30
- Programs
- 8
- Drugs
- 6
- Patents
- 31
vilamakitug
Phase 2 · small molecule · Axial Spondyloarthritis
vilamakitug for Axial Spondyloarthritis is a Phase 2 program (small_molecule) at XBiotech Germany GmbH with 1 ClinicalTrials.gov record(s).
Internal code PT064
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- XBiotech Germany GmbH
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Axial Spondyloarthritis
- Status
- active
- Trials
- 1